Approving and marketing lethal drugs, while concealing the results of studies that reveal deadly side affects, should be a jailable offense. by Evelyn Pringle This
Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft “failure to warn” cases
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) In a stunning federal court order JAMES M. ROSENBAUM, US Chief District Judge in Minnesota, overturned FDA-supported pre-emption arguments
Antidepressant efficacy may be overblown-experts
by Karla Gale Reuters NEW YORK (Reuters Health) – Antidepressants, for the most part, do not provide meaningful benefit, two investigators in the UK argue
2000 study by Merck showed Vioxx risk
Results not given to FDA BY ED SILVERMAN Star-Ledger Staff Merck officials five years ago conducted an internal analysis that revealed patients taking Vioxx were
FDA to Boost ADHD Drug Warnings
Panel Seeks Clearer Labels Detailing Possible Problems Linked to the Medications By JENNIFER CORBETT DOOREN DOW JONES NEWSWIRES A Food and Drug Administration panel said
